Joseph Wright - 15 Sep 2021 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
PRESIDENT, INTERNATIONAL
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
15 Sep 2021
Net transactions value
-$547,400
Form type
4
Filing time
17 Sep 2021, 15:55:00 UTC
Previous filing
24 May 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $172,700 +10,000 +81% $17.27* 22,343 15 Sep 2021 Direct
transaction MMSI Common Stock, No Par Value Sale $720,100 -10,000 -45% $72.01 12,343 15 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -10,000 -100% $0.000000* 0 15 Sep 2021 Common Stock 10,000 $17.27 Direct F2
holding MMSI Non-qualified stock options (right to buy) 20,000 15 Sep 2021 Common Stock 20,000 $16.05 Direct F3
holding MMSI Non-qualified stock options (right to buy) 25,000 15 Sep 2021 Common Stock 25,000 $28.20 Direct F4
holding MMSI Non-qualified stock options (right to buy) 25,000 15 Sep 2021 Common Stock 25,000 $44.80 Direct F5
holding MMSI Non-qualified stock options (right to buy) 30,000 15 Sep 2021 Common Stock 30,000 $55.73 Direct F6
holding MMSI Non-qualified stock options (right to buy) 16,722 15 Sep 2021 Common Stock 16,722 $37.71 Direct F7
holding MMSI Non-qualified stock options (right to buy) 9,681 15 Sep 2021 Common Stock 9,681 $56.25 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.12, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
F3 Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
F4 Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
F5 Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
F6 Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
F7 Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
F8 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.